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A Corepressor/Coactivator Exchange Complex
Required for Transcriptional Activation by Nuclear
Receptors and Other Regulated Transcription Factors
short LXXLL helical motif present in the majority of the
coactivators (Heery et al., 1997; Torchia et al., 1997),
while interaction of the corepressor N-CoR/SMRT with
the unliganded nuclear receptors is dependent on a
conserved motif, referred to as the CoRNR box or as
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not limited to nuclear receptors, and many other classes
of DNA binding transcription factors, such as homeodo-
main factors (Xu et al., 1998; Asahara et al., 1999; Li etSummary
al., 2002) can recruit both coactivators and corepres-
sors, with a correct balance between corepressor andThe mechanisms that control the precisely regulated
coactivator levels modulating the threshold of transcrip-switch from gene repression to gene activation repre-
tional activation. In the case of nuclear receptors, ligandsent a central question in mammalian development.
binding not only induces the dismissal of corepressorsHere, we report that transcriptional activation medi-
and the recruitment of coactivators, but it can also regu-ated by liganded nuclear receptors unexpectedly re-
late the rapid turnover of receptors and coactivators onquires the actions of two highly related F box/WD-40-
DNA (McNally et al., 2000; Shang et al., 2000; Reid etcontaining factors, TBL1 and TBLR1, initially identified
al., 2003).as components of an N-CoR corepressor complex.
Furthermore, degradation of nuclear receptors hasTBL1/TBLR1 serve as specific adaptors for the recruit-
been linked to transcriptional activity on the basis ofment of the ubiquitin conjugating/19S proteasome
observations that inhibition of the proteasome activitycomplex, with TBLR1 selectively serving to mediate a
abolishes transcriptional activation mediated by estro-required exchange of the nuclear receptor corepres-
gen, androgen, and retinoic acid receptor- (Lonard etsors, N-CoR and SMRT, for coactivators upon ligand
al., 2000; Gianni et al., 2002; Kang et al., 2002; Lin etbinding. Tbl1 gene deletion in embryonic stem cells
al., 2002). It has also been reported that the levels ofseverely impairs PPAR-induced adipogenic differen-
several nuclear receptor coactivators are regulated bytiation, indicating that TBL1 function is also biologically
ubiquitylation/degradation (Yan et al., 2003).indispensable for specific nuclear receptor-mediated
Interestingly, many transcription factors have their ac-gene activation events. The role of TBLR1 and TBL1 in
tivation domains overlapping with the elements that sig-cofactor exchange appears to also operate for c-Jun and
nal for degradation, suggesting a general correlationNFB and is therefore likely to be prototypic of similar
between activator potency and instability (Molinari et
mechanisms for other signal-dependent transcription
al., 1999; Salghetti et al., 2000). For example, Myc degra-
factors. dation and transcriptional activity are tightly linked, with
the F box protein Skp2 acting as a potent coactivator
Introduction (Kim et al., 2003; Von der Lehr et al., 2003).
The ubiquitin/proteasome pathway is widely used to
Nuclear receptors are a class of transcription factors control the turnover of many regulatory proteins, and
widely used in development and homeostasis to regu- protein polyubiquitylation provides the specific recogni-
late critical processes. Binding of specific ligands regu- tion signal that marks the substrate for degradation, but
lates many nuclear receptors, and their transcriptional there is increasing evidence that the ubiquitylation of a
functions are mediated by cofactors that are broadly protein may serve purposes not exclusively linked to
defined as coactivators and corepressors on the basis its degradation (reviewed in Conaway et al., 2002 and
of their requirement for gene transcriptional activation Muratani and Tansey, 2003).
or repression (reviewed in Mangelsdorf et al., 1995; The ubiquitylation process is characterized by an en-
Glass and Rosenfeld, 2000; McKenna and O’Malley, zymatic cascade with an E1 ubiquitin-activating en-
2002). Ligand-dependent recruitment of coactivators to zyme, several E2 ubiquitin-conjugating enzymes (Ubc),
nuclear receptors is usually mediated by a conserved and multiple E3 ubiquitin ligases (reviewed in Glickman
and Ciechanover, 2002). E3 ligases serve as the specific
recognition factors, and they can be broadly divided*Correspondence: mrosenfeld@ucsd.edu (M.G.R.), dwrose@popmail.
ucsd.edu (D.W.R.) into HECT E3 ligases and RING E3 ligases. RING finger-
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containing E3 ligases can either function as single pro- other expected coactivators, as well as to the androgen-
regulated kallikrein 2 promoter upon 5-dihydroxytestos-teins or in multisubunit complexes (reviewed in Jackson
et al., 2000). Specific ring finger (SCF) complexes use terone (DHT) stimulation (Figure 1C). Failure of TBL1
recruitment to the pS2 promoter in the ER null cell lineF box proteins as variable subunits responsible for spe-
cific substrate recognition (reviewed in Patton et al., MDA-MB-231 proved that TBL1 recruitment to the ERE
response element was dependent on binding of the1998). The F box domain is a protein-protein interaction
motif, usually found in the amino-terminal portion of a liganded receptor (Figure 1D). Furthermore, endoge-
nous TBL1 could be coimmunoprecipitated with the es-protein and often associated with leucine-rich repeats
(LRRs) or WD-40 repeats in the carboxy-terminal region trogen receptor in the presence of ligand and could be
also coimmunoprecipitated with coactivators such as(reviewed in Kipreos and Pagano, 2000).
Transducin -like 1 (TBL1) is an F box/WD-40-containing RIP140 and CBP/p300 both in the presence or absence
of ligand (Figure 1E and data not shown), suggestingprotein, originally cloned in relationship to an X-linked
human disorder called Ocular Albinism with late-onset that receptor-dependent recruitment of TBL1 is proba-
bly indirect, based on interactions with other cofactorsSensorineural Deafness (OASD), in which a microdele-
tion of the C-terminal part of the Tbl1 gene was sug- and, perhaps, with histones (Guenther et al., 2000; Yoon
et al., 2003).gested to be responsible for the hearing defect (Bassi
et al., 1999). In Drosophila, the homolog of TBL1, Ebi, We next investigated whether TBL1 was functionally
required for estrogen receptor-mediated transcrip-has been genetically linked to the ubiquitin-dependent
degradation of Tramtrack88 by the Phyl/Sina complex tional activation. Single cell microinjection of specific
purified IgGs against TBL1 blocked the activation of anin response to EGFR signaling during R7 photoreceptor
cell development (Dong et al., 1999; Boulton et al., 2000). ERE-dependent reporter upon E2 treatment (Figure 1F),
while they did not have any effect with the antagonistInterestingly, biochemical purification of the N-CoR and
SMRT corepressor complexes showed that they both 4-hydroxy-tamoxifen (4-OHT) (Figure 1G). TBL1 was
also found to be required for the E2-dependent activationcontain TBL1 and HDAC3 (Guenther et al., 2000; Li et
al. 2000). Zhang and colleagues (2002) subsequently of the regulatory region of the pS2 promoter (Figure 1H).
To confirm these findings by an independent approach,identified GPS2 and TBLR1, which shares very high
homology with TBL1, as additional components of the we designed a specific siRNA against human Tbl1, effec-
tively reducing the level of Tbl1 mRNA to undetectableN-CoR/SMRT complex.
In this manuscript, we report that the corepressors- levels, based on RT-PCR analysis of TBL1 expression
performed on several hundred microinjected cells. Mi-associated F box/WD-40 proteins TBL1 and TBLR1 are
unexpectedly required for gene activation by liganded croinjection of this specific siRNA into MCF7 nuclei abol-
ished activation of the ERE-dependent reporter uponnuclear receptors, as well as by other classes of regu-
lated DNA binding transcription factors, based on their ligand stimulation, while control siRNA did not have any
effect (Figure 1I), confirming that TBL1 is required forability to mediate corepressor/coactivator exchange by
a ligand-dependent recruitment of the ubiquitin/19S transcriptional activation by the estrogen receptor. Anal-
ysis of androgen receptor-mediated activation, usingproteasome complex.
both an artificial ARE-response promoter as well as the
regulatory region of the PSA promoter, revealed a similarResults
requirement for TBL1 (Figure 1J).
Interestingly, TBL1 proved to be required for activa-TBL1 Is required for Nuclear
tion by thyroid hormone receptor (T3R) and peroxisomeReceptor-Mediated Activation
proliferator-activated receptor  (PPAR) (Figure 1K),N-CoR has been proven to be a component of a large
but not required for retinoic acid receptor (RAR)-medi-number of distinct complexes (reviewed in Jepsen and
ated activation (Figure 1L). In contrast, microinjectionRosenfeld, 2002), which are probably combinatorially
of TBL1 antibody partially released transcriptional re-required to mediate repression in a promoter- and cell-
pression mediated by the unliganded RAR (Figure 1L),specific fashion. To further define the role of the F box/
suggesting that, in this case, TBL1 functions only asWD-40 protein, TBL1, initially purified as a component
a corepressor.of an N-CoR corepressor complex that also contained
HDAC3 (Guenther et al., 2000; Li et al., 2000), we used
the chromatin immunoprecipitation (ChIP) analysis. We TBL1 Gene Deletion in ES Cells and Analysis
of Nuclear Receptor-Regulated Genesfound, as expected, that TBL1 was present on the RAR
and the HoxA1 promoters in absence of ligand but was In order to independently confirm the unexpected role
for TBL1 in gene activation events, we employed a ge-only partially released upon retinoic acid binding, con-
comitantly with the dismissal of the corepressors N-CoR netic approach deleting the Tbl1 genomic locus in ES
cells to investigate the role of TBL1 in regulated develop-and HDAC3 and with the recruitment of coactivators
such as CBP or SRC-1 and the acetylation of histone mental processes. The targeting vector replaced the
5-terminal part of the gene with EGFP cDNA, introduc-H3 (Figure 1A and data not shown).
Analyzing genes regulated by the estrogen receptor ing a strong splicing acceptor site from the -globin
gene in order to avoid any cryptic splicing event over the(ER) or the androgen receptor (AR), we unexpectedly
observed recruitment of TBL1 in response to ligand- EGFP coding sequence (Figure 2A), and G418-resistant
R1-ES cells were screened for homologous recombina-dependent gene activation. TBL1 was recruited on the
ERE response element of the pS2 promoter in response tion events by Southern blot analysis with specific 5-
and 3- probes; two positive clones were further con-to estradiol (E2) stimulation (Figure 1B), together with
TBL1/TBLR1: Nuclear Corepressor Exchange Factors
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Figure 1. TBL1 Is Required for Transcriptional Activation by Nuclear Receptors
(A) Occupancy of the RAR promoter by RAR, N-CoR, HDAC3, and TBL1 analyzed by chromatin immunoprecipitation (ChIP) in murine P19
cells. Left panel cells were treated for 1 hr with retinoic acid (RA).
(B) ChIP analysis of the occupancy of the pS2 promoter upon activation by estradiol (E2). TBL1 was recruited to the pS2 promoter within 15
after ligand stimulation.
(C) TBL1 recruitment to the androgen-regulated kallikrein 2 promoter upon dihydroxytestosterone (DHT) binding.
(D) TBL1 was not found by ChIP on the pS2 promoter in the ER null cell line MDA-MB-231 stimulated by E2.
(E) Endogenous coimmunoprecipitation of TBL1 with ER and Rip140 performed in estradiol-stimulated MCF-7 cells.
(F) Single cell nuclear microinjection of purified IgGs against TBL1 inhibited E2-dependent transcriptional activation in Rat1 cells.
(G) TBL1 IgGs microinjection did not have any effect of 4-hydroxy-tamoxifen (4-OHT)-induced repression of the ERE/LacZ reporter.
(H) TBL1 IgGs microinjection blocked activation of a 1.2 kb fragment of the pS2 promoter upon stimulation with E2 in MCF7 cells.
(I) Single cell microinjection of a specific siRNA in MCF7 nuclei induced selective downregulation of TBL1 RNA, as measured by RT-PCR
analysis in 100 injected cells, and blocked activation of the pS2 promoter upon E2 stimulation. Injection of control siRNA had no effect.
(J) For androgen receptor, TBL1 was required for activation of ARE/LacZ reporter and the PSA promoter.
(K) TBL1 IgGs microinjection also inhibited PPAR-mediated activation of a PPAR-RE/LacZ reporter upon Rosiglitazone (ROSI) stimulation
and T3R-mediated activation of the T3RE/LacZ reporter by T3.
(L) TBL1 injection did not have any effect of RAR-mediated activation of the DR5/LacZ reporter in presence of RA.
firmed by PCR analysis (Figures 2B and 2C). Because ysis confirmed that TBL1 protein expression was com-
pletely abolished in the recombinant cells (Figure 2D).the Tbl1 gene is located on the X chromosome and
R1-ES cells are male, the positive clones identified are The recombinant Tbl1/Y ES cells provided a powerful
model in which to analyze TBL1 function for the activa-Tbl1 hemizygous clones (Tbl1/Y), and Western blot anal-
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Figure 2. Targeted Disruption of the Tbl1 Gene in Embryonic Stem Cells
(A) Schematic representation of the Tbl1 genomic locus and of the targeting vector showing the restriction sites relevant for the use of specific
5 and 3 probes in Southern blot analysis and the primers (arrows) used for PCR analysis.
(B) Southern blot analysis of ES cell clones digested with BamHI and hybridized with the 3-external probe or digested with BstEII and
hybridized with a 5-specific internal probe.
(C) PCR analysis of genomic DNA extracted from ES cells using the primers indicated in (A), designed to amplify fragments of different sizes
in the wild-type or the recombinant clones.
(D) Immunoblot of whole-cell extracts (WCE), nuclear extracts (NE), and cytoplasmic extracts (CE) with TBL1 antibody showing that TBL1
protein is absent in the extracts from Tbli/Y ES cells.
(E) RT-PCR analysis of RAR target genes in ES cells following 6 hr and 24 hr of RA treatment: RAR, HoxA1, and c-Myc gene expression
changes upon ligand stimulation were not affected by Tbl1 gene deletion.
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tion of known endogenous nuclear receptor target genes identified an additional member of the TBL1 family,
upon ligand stimulation. Interestingly, retinoic acid TBLR1, encoded by a distinct gene located on autoso-
(RA)-induced genes, such as RAR and HoxA1 (de The mal murine Chr 3. The TBLR1 protein product is highly
et al., 1989; Langston et al., 1997), were upregulated homologous to the TBL1 protein encoded by the Tbl1X
equally well in the Tbl1/Y as in the wild-type ES cells gene (Figure 3A). Additionally, the database search
(Figure 2E), confirming the observations that TBL1 is showed that in the human genome, Tbl1X has a con-
not required for retinoic acid receptor-mediated tran- served homolog, Tbl1Y, on the Y chromosome. How-
scriptional activation. Similarly, a gene downregulated ever, in the murine genome, the Tbl1Y gene does not
by retinoic acid-induced differentiation, c-myc (Dean et seem to be conserved as murine Tbl1X was mapped
al., 1986), showed the same pattern of expression in to a more proximal chromosomal position, far from its
wild-type and Tbl1/Y cells, confirming that Tbl1 hemizy- neighboring genes in human Xp22.3 (Disteche et al.,
gous ES cells are not impaired in their response to reti- 1998) and among genes that do not have conserved
noic acid. In contrast, Tbl1/Y cells are no longer able homologs on the Y chromosome. Furthermore, our data
to respond to estrogen treatment as shown by the lack showing loss of nuclear receptor-mediated transcrip-
of activation of known target genes, such as pS2, ER, tional responses in the murine Tbl1/Y ES cells also
and ER, (Figure 2F) or to T3 stimulation as exemplified suggest the absence of a TBL1Y protein able to compen-
by the CAMKIV gene (Figure 2F), which is known to be sate for Tbl1X deletion.
induced in ES cells by thyroid hormone stimulation (Liu Overexpressed Tbl1/Y ES cells of either Flag-tagged
et al., 2002). Thus, Tbl1 gene deletion provides indepen- TBL1 or Myc-tagged TBLR1 and Western blots shown in
dent confirmation of the observation that TBL1 is re- Figure 3B clearly confirmed that our guinea pig -TBL1
quired for transcriptional activation by estrogen and thy- antibody was highly specific for TBL1. An additional
roid hormone receptors. rabbit antibody against a peptide specific for TBLR1 was
In order to explore whether these results were specific then successfully raised, permitting us to test whether
for few targets or reflected a widespread requirement RAR-mediated activation might require TBLR1 instead
for TBL1, RNA profiling was performed to analyze the of TBL1. Indeed, microinjection of the specific TBLR1
ability of the recombinant ES cells to respond to different
IgGs blocked retinoic acid-induced activation of a DR5
hormonal stimulations. The results of multiple microar-
element-dependent reporter (Figure 3C). Independent
rays performed on the Codelink three-dimensional plat-
confirmation of this result was obtained by microinjec-form, comparing RNA extracted from wild-type and
tion of a specific siRNA for TBLR1, with control siRNATbl1/Y ES cells treated with retinoic acid and thyroid
injection having no effect (Figure 3C). Chromatin immu-hormone, are plotted in Figures 2G and 2H. For each
noprecipitation analysis revealed that TBL1 is preferen-treatment, all the genes exhibiting a statistically signifi-
tially bound to the unliganded receptor and partiallycant upregulation of more than 3.5-fold (Sasik et al.,
dismissed upon ligand, while TBLR1 is preferentially2002) in the wild-type were compared to their counter-
recruited to the RAR promoter upon ligand stimulationparts in Tbl1/Y cells. This broader analysis revealed
(Figure 3C). T3R, ER and PPAR receptors all requiredthat virtually all the RA-induced genes were activated
both TBL1 and TBLR1, as removal of either of theseas well in the Tbl1/Y ES cells (Figure 2G), including
factors, by antibody or siRNA microinjection, was suffi-known targets of retinoic-induced neuronal differentia-
cient to abrogate transcriptional activation (Figure 3Dtion in embryonic stem cells, such as several Hox genes
and data not shown). Thus, TBLR1 function is required(HoxA1, HoxA2, HoxA5, Hox-1.4, Hox-2.6) (reviewed in
for transcriptional activation by all the nuclear receptorsBoncinelli et al., 1991), Stra6, Stra8, Cyp26, and Procol-
analyzed; T3R, ER, and PPAR receptors additionallylagen type IV. In contrast, T3-dependent gene activation
require TBL1, while RAR does not.was almost completely impaired in Tbl1/Y cells, and
In order to establish whether the selective requirementthe majority of genes that were found upregulated upon
for TBL1 and TBLR1 was specific for nuclear receptors,T3 treatment in wild-type ES cells were not induced in
we also tested several other unrelated transcriptionthe Tbl1/Y cells (Figure 2H), including known thyroid
factors. Interestingly, NF-B-mediated activation onhormone targets, such as type I iodothyronine deio-
canonical sites required both TBL1 and TBLR1, whiledinase, the oncogene JunB, and several Gap junction
AP-1-mediated activation depended exclusively onsubunits. Similarly, upregulation of estrogen-dependent
TBLR1 action (Figure 3E). In contrast, CREB-mediatedtarget genes was profoundly impaired in Tbl1/Y cells
activation did not require either TBL1 or TBLR1 (Figure(data not shown). Thus, TBL1 is broadly required for
3E). Thus, TBL1/TBLR1 usage was not necessarily re-cellular responses to thyroid hormone and estradiol,
stricted to nuclear receptors, and a clear specificity be-while retinoic acid-induced gene activation occurs inde-
tween TBL1 and TBLR1 could also be observed in thependently of TBL1.
case of other classes of DNA binding transcription
factors.TBL1 Gene Family: Specificity for Nuclear
As an independent approach, we analyzed TBL1 andReceptor Regulation
TBLR1 requirement for NF-B transcriptional activationIn repeating a purification of N-CoR- and HDAC3-con-
taining complexes, Zhang and colleagues (2002) have by using a pathway-specific gene expression array sys-
(F) RT-PCR analysis of genes activated in response to estradiol and thyroid hormone (5d) stimulation was not observed in the Tbli/Y ES cells.
(G) RNA profiling of ES cells wild-type and Tbl1/Y treated with 1 M retinoic acid for 6 hr, plotting genes upregulated at least 3.5-fold in the
wild-type cells.
(H) RNA profiling of ES cells treated for 12 hr with 10 nM thyroid hormone.
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Figure 3. TBL1 Family: TBL1X and TBLR1 Have Specific Non-Overlapping Functions
(A) Schematic representation of murine TBL1 and TBLR1 showing the chromosomal locations of the genes, the position of F box and WD-40
domains, and the homology between TBL1 and TBLR1.
(B) Immunoblot of whole-cell extracts from Tbli/Y ES cells transfected with Flag-TBL1 or Myc-TBLR1 showing the specificity of TBL1 antibody.
(C) Single-cell microinjection of -TBLR1 antibody specifically blocked activation of the DR5/LacZ reporter upon RA stimulation, while
microinjection of TBL1 antibody did not. ChIP analysis of the occupancy of the RAR promoter in 293 cells showing TBL1 partial release
and TBLR1 recruitment upon RA treatment.
(D) Selective requirement of TBL1 and TBLR1 for transcriptional activation by T3R, ER, and PPAR.
(E) Selective requirement of TBL1/TBLR1 by other transcription units in single cell microinjection assay, using a LacZ reporter driven by the
NFB site present in the E-selectin promoter upon TNF stimulation, an AP1-dependent reporter by TPA and a CREB-dependent reporter
by forskolin.
(F) RNA profiling of TNF-stimulated HUVEC cells either uninjected or injected with specific siRNAs against Tbl1 and TblR1 on GE-Arrays.
tem containing 96 gene-specific cDNA fragments, hy- components of the nuclear receptor superfamily, even
though the turnover of the receptor is not unambigu-bridized with RNA extracted from 500 HUVEC endothe-
lial cells, either uninjected or injected with the specific ously functionally linked to transcriptional activity (re-
viewed in Dennis et al., 2001).siRNAs for Tbl1 and TblR1. As predicted, the activation
of all the NFB target genes induced in these cells upon As expected, microinjection of an antibody against
the S1/Rpn2 subunit of the 19S proteasome (Figure 4A)TNF stimulation was lost when either TBL1 or TBLR1
was depleted (Figure 3F). or pretreatment of the cells with the proteasome inhibi-
tor MG132 (data not shown) blocked ligand-induced
transcriptional activation for T3R, ER, PPAR, and RAR,TBL1 Mediates the Recruitment of the Ubiquitin-
Proteasome Complex confirming, in our experimental model, that ubiquitin-
dependent proteasomal degradation is required for nu-Because TBL1/TBLR1 are putative F box/WD40 repeat
proteins, it seemed reasonable to consider that their clear receptor-mediated transcription.
To investigate whether the function of TBL1 or TBLR1requirement for nuclear receptor function might reflect
a role in the recruitment of the ubiquitin/proteasome in transcriptional activation might be to recruit the ubi-
quitin-conjugating machinery, we tested whether TBL1machinery. Degradation of nuclear receptors upon li-
gand binding has been reported for almost all the domains important for binding to ubiquitin ligases were
TBL1/TBLR1: Nuclear Corepressor Exchange Factors
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also required for transcriptional activation by TBL1- that transcriptional activation by RAR upon ligand stimu-
dependent nuclear receptors. Indeed, deletion of the lation is dependent on the F box-interacting subunit,
putative F box, ubiquitin ligase-recruiting domain, was SKP1A, of many SCF complexes as specific siRNAs
enough to abolish the ability of TBL1 or TBLR1 to rescue against the two isoforms SKP1Aa and SKP1Ab fully ab-
transcriptional activation by any of the receptors tested rogated SKP1A expression by 72 hr and inhibited RAR-
when endogenous TBL1 or TBLR1 had been specifically mediated transcriptional activation, while nonspecific
blocked by antibody microinjection (Figures 4B and 4C). siRNAs were without effect (Figure 4I).
Deletion of the WD-40 C-terminal region also blocked These data are consistent with nuclear receptor activ-
TBL1 transcriptional function (Figure 4B). To confirm the ity being modulated by ubiquitylation and suggest that
specificity of these results, we also injected specific TBL1/TBLR1 are the specific F box/WD-40 adaptor pro-
siRNAs against TBL1 and TBLR1 and the unrelated teins used for the recruitment of the ubiquitin-conjugat-
F box/WD40 proteins Fbx3 and Fbx8 and found that only ing enzyme UbcH5 to specific targets. However, a com-
TBL1 and TBLR1 were required for nuclear receptor- plete and exhaustive description of the network of
mediated transcriptional activation (Figure 4D). enzymes used by each receptor will clearly require fur-
To confirm that TBL1 is capable of interactions with ther analysis in the future because specific interactions
ubiquitin-conjugating enzymatic activity, we performed among E3 ligases and specific ubiquitin-conjugating E2
immunoprecipitation of endogenous TBL1 from 293 enzymes have yet to be fully defined.
cells followed by an in vitro ubiquitylation assay, as- Increasing evidence has suggested a direct recruit-
sessing ubiquitylation activity by formation of multiubi- ment of the 19S proteasome to specific promoters (re-
quitin chains from free ubiquitin (Figure 4E). High molec- viewed in Lipford and Deshaies, 2003). Thus, having
ular weight biotin-multiubiquitin chains were detected observed requirement of the S1/Rpn2 subunit for nu-
in presence of recombinant E1 enzyme and TBL1-asso- clear receptor-mediated transcriptional activation (Fig-
ciated proteins, but not in a control sample for immuno- ure 4A), we further tested other subunits. Chromatin
precipitation of nonspecific complexes (Figure 4E). Ad- immunoprecipitation analysis in retinoic acid-induced
dition of exogenous recombinant UbcH/E2 enzymes 293 cells confirmed that two other AAA-ATPase sub-
was not necessary, although ubiquitylation activity ap- units, SUG1/Rpt6 and Tbp7/Rpt3, were locally recruited
peared increased by the specific addition of UbcH5 (Fig- to the RAR promoter upon ligand stimulation (Figure
ure 4E). We further tested whether TBL1 and TBLR1 4J). Also, specific siRNAs against the S1/Rpn2 or against
could interact directly or indirectly with UbcH5, observ- the AAA-ATPases subunits SUG1/Rpt6 and SUG2/Rpt4
ing coimmunoprecipitation of Myc-tagged TBLR1 with were designed and tested in microinjection analysis, in
HA-tagged UbcH5 using either the Myc or the HA which all three subunits proved to be required for
antibody (Figure 4F) and similar, although weaker, inter- PPAR-mediated transcriptional activation (Figure 4K).
actions with TBL1 (data not shown). Furthermore, dele-
tion of the F box impairs TBLR1 ability to interact with TBL1/TBLR1 Function in
UbcH5 and deletion of the entire N terminus completely Transcriptional Activation
abrogates it, while deletion of the C terminus results in
Next, we wished to determine the mechanisms by which
increased binding (Figure 4F).
TBL1-mediated recruitment of the ubiquitin-machinery
Chromatin immunoprecipitation analysis performed
regulates gene activation events. In the case of estrogen
on the pS2 promoter after estrogen stimulation revealed
and androgen receptors, it has been reported that bind-that specific components such as the UbcH5 enzyme
ing of the receptor to the promoter is not stable butand the S1 subunit of the 19S proteasome were recruited
undergoes a local turnover (Figure 4D and Shang et al.,to the promoter in a ligand-dependent fashion, with ki-
2000, 2002; Kang et al., 2002), and it is well establishednetics of recruitment very similar to those observed for
that nuclear receptors are targeted to protein degrada-the receptor itself (Figure 4G). The recruitment of these
tion upon ligand binding, as several reports have de-factors seems to be specific because many ubiquityla-
scribed a global downregulation of the receptor proteintion enzymes were not recruited to the same promoter
level after ligand stimulation. Thus, a possible explana-(Figure 4G and data not shown).
tion for TBL1 function in gene activation could be inMicroinjection of specific antibodies against the dif-
mediating the degradation of the receptor, which hasferent UbcH enzymes revealed that, in the case of estro-
been suggested to be the reason for which the protea-gen receptor, UbcH5 was not only physically recruited
some is required for receptor-mediated transcriptionalon the promoter, as shown on the pS2 promoter (Figure
activation.4H), but also appeared to be functionally required for
We tested this hypothesis by analyzing whether thetranscriptional activation of an ERE-dependent reporter
global downregulation of the estrogen receptor protein(Figure 4H). Interestingly, we found that UbcH5 was gen-
level upon ligand treatment would be affected by theerally required by all the receptors analyzed (Figure 4H).
deletion of the Tbl1 gene. First, we confirmed thatTo use an independent method to confirm this require-
ER protein could be downregulated in a proteasome-ment, we designed specific siRNAs that fully abrogated
dependent fashion, following estrogen stimulation, inUbcH5A, B, and C expression and confirmed that UbcH5
both MCF7 and in NIH-3T3 cells; however, in the pituitaryis required for transcriptional activation (Figure 4I). Inter-
cell line T3, only limited degradation occurs and onlyestingly, we also found receptor-specific recruitment of
at much later times after ligand stimulation (Figure 5Aadditional enzymes: the E2 enzyme UbcH7 for ER; the
and data not shown). Surprisingly, we did not observeHECT E3 ligases MDM2 and E6AP and UbcH7 in the
any downregulation of ER in ES cells, even though incase of RAR; and UbcH2 and E6AP in the case of thyroid
hormone receptor (Figure 4H). Additionally, we showed these cells TBL1 is fully required for E2-dependent gene
Cell
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activation; indeed we found that ER protein level was and this effect is partially abrogated by overexpression
of TBL1N, suggesting that HDAC3 may also be a targetactually upregulated, while it remained essentially un-
changed in the Tbl1/Y cells (Figure 5B). Because we of TBL1-induced degradation (Figure 5D).
If the dismissal or degradation of the N-CoR corepres-observed impairment of the ES cells to respond to estro-
gen stimulation in absence of TBL1 (Figure 2F and data sor complex was the required step mediated by TBL1
and/or TBLR1, then TBL1 and TBLR1 would no longernot shown), these data reveal that the requirement for
TBL1 for ER-mediated transcriptional activation cannot be required for activation in absence of N-CoR. Thus,
using siRNAs against N-CoR and SMRT, which are effec-be explained as a consequence of TBL1 being responsi-
ble for estrogen receptor degradation. These data raised tive in bringing them to undetectable levels by 24 hr
after siRNA nuclear microinjection (data not shown), wethe intriguing possibility that TBL1 is responsible for
ubiquitylation/degradation of other cofactors and/or tested whether either TBL1 or TBLR1 were required for
transcriptional activation in the absence of these twocomponents of the transcriptional machinery required
for nuclear receptor functions. corepressors. We found that activation of T3R in re-
sponse to ligand was still completely dependent onBecause TBL1/TBLR1 are components of an N-CoR
corepressor complex, we tested the hypothesis that TBL1 independent of the presence of N-CoR/SMRT (Fig-
ure 5E). However, transcriptional activation upon thyroidTBL1/TBLR1-mediated recruitment of the ubiquitin/19S
proteasome would be required for N-CoR ubiquitylation, hormone treatment in the absence of both N-CoR and
SMRT now became independent of TBLR1, even thoughdismissal, and degradation. Interestingly, Zhang et al.
(1998) have reported proteasomal degradation of N-CoR, removal of either N-CoR or SMRT alone was not suffi-
cient to cause ligand-independent activation in absencebased on its interaction with the E3 ligase Siah2. In the
case of -catenin and Tramtrack88, both mammalian of TBLR1 (Figure 5E). Similar analysis of PPAR-medi-
ated transcriptional activation showed that TBLR1 re-Siah and its Drosophila homolog, Sina, have been de-
scribed to use TBL1 as their adaptor subunit responsible quirement could be overcome by eliminating both
N-CoR and SMRT (Figure 5E). To explore this further, wefor specific substrate recognition (Dong et al., 1999;
Boulton et al., 2000; Matsuzawa and Reed, 2001); thus, analyzed the two transcription units that are exclusively
dependent on TBLR1, but not on TBL1, for transcrip-we investigated whether N-CoR degradation could also
be TBL1 dependent. First, we analyzed the levels of the tional activation. In the case of both RAR- and AP1-
mediated transcriptional activation, removal of N-CoRcorepressors N-CoR and HDAC3 upon UV stimulation
in the same biological system in which TBL1/Siah-medi- and SMRT by siRNAs injection was also sufficient to
make transcriptional activation independent from TBLR1ated degradation of -catenin, via p53 activation, was
reported (Matsuzawa and Reed, 2001). Interestingly, in (Figure 5F). Thus, loss of the corepressors N-CoR and
SMRT serves in all the cases we have analyzed as aNIH-3T3 cells, the levels of both proteins were downreg-
ulated upon UV treatment (Figure 5C). To test whether “reverting mutation,” restoring transcriptional activation
in response to ligand in the absence of TBLR1, but notthis downregulation was TBL1 dependent, we induced
N-CoR degradation by overexpression of Siah1 or Siah2, in the absence of TBL1.
Together, these data suggest that the concomitantp53-inducible genes that are the rate-limiting factors of
the SCFTbl1 complex (Amson et al., 1996; Matsuzawa requirement for both TBL1 and TBLR1 by many nuclear
receptors reflects a complex series of steps, with TBLR1and Reed, 2001). As predicted, the N-terminal region
of TBL1 behaves as a dominant-negative and its overex- action being required by all the nuclear receptors ana-
lyzed because of its ability to mediate the dismissal ofpression is sufficient to abrogate N-CoR degradation
(Figure 5D), suggesting that N-CoR proteasomal degra- specific corepressors and their subsequent degrada-
tion. The requirement for TBL1 in transcriptional activa-dation is TBL1 dependent. Similarly, HDAC3 protein
level is highly decreased upon Siah2 overexpression, tion, on the other hand, does not exclusively reflect
Figure 4. TBL1 Recruits the Ubiquitin/Proteasome Complex, Required for Nuclear Receptors Transcriptional Activity
(A) In Rat1 cells, nuclear microinjection of IgGs against the S1 subunit of the 19S proteasome blocked nuclear receptor-mediated transcrip-
tional activation.
(B) F box and WD-40 domains of TBL1 are needed for mediating transcriptional activation, as expression vectors in which those domains
have been deleted could not rescue transcriptional activation by T3R, ER, or PPAR when this was blocked by -TBL1 IgGs microinjection.
(C) In a similar assay, the F box of TBLR1 is required for ER- and RAR-mediated activation.
(D) Microinjection of specific siRNAs against Tbl1 and TblR1 abrogated ER- and PPAR-mediated activation, while depletion of the unrelated
F box/WD40 factors FBX3 and FBX8 did not have any effect.
(E) In vitro ubiquitin-conjugation assay performed on MCF7 whole-cell extracts immunoprecipitated with -TBL1 antibody. The protein complex
associated with TBL1 had intrinsic ubiquitylation enzymatic activity without the need of adding recombinant E2 enzymes.
(F) Coimmunoprecipitation in either direction of HA-UbcH5 with Myc-TBLR1 full-length or N terminus, but not with TBLR1 mutants in which
either the C terminus or the F box have been deleted.
(G) ChIP analysis of the kinetics of occupancy of the pS2 promoter by ER, the proteasome subunit S1, and various E2/UbcH enzymes following
estradiol stimulation.
(H) Nuclear microinjection of IgG specific for different E2 ubiquitin-conjugating enzymes and E3 ligases revealed nuclear receptor specificity.
The schematic indicates factors required for transcriptional activation by each nuclear receptor in quiescent Rat1 cells.
(I) Depletion of UbcH5 and SKP1A by specific siRNAs microinjection abrogated RAR-mediated transcriptional activation.
(J) Recruitment of the AAA-ATPase subunits of the 19S proteasome SUG1/Rpt6 and Tbp7/Rpt3 to the RAR promoter upon ligand stimulation.
(K) Microinjection of specific siRNAs against the 19S proteasome subunits SUG1/Rpt6, SUG2/Rpt4, and S1/Rpn2 blocks activation of a
PPAR-dependent reporter upon ligand stimulation.
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Figure 5. TBL1/TBLR1 Function in Mediating
N-CoR Degradation
(A) Inhibition of the proteasome activity by
MG132 treatment blocked ER protein deg-
radation upon estrogen stimulation.
(B) Immunoblot analysis of extracts from E2-
treated embryonic stem cells. The global level
of ER protein in wild-type ES cells increased
upon estrogen treatment and remained un-
changed in Tbli/Y ES cells.
(C) Immunoblot with p53, N-CoR, and H-
DAC3 of NIH-3T3 cell extracts lysed at differ-
ent times after irradiation with 50 J/cm2 UV.
p53 induction can be first observed after 3
hr, while N-CoR and HDAC3 downregulation
occur at 19 and 24 hr, respectively.
(D) Immunoblot with Flag antibody of 293
cell extracts upon transient transfection with
Flag-N-CoR/HA-Siah1/HA-Siah2/Flag-TBL1
and Flag-TBL1WD40. The N terminus of
TBL1, acting as a dominant-negative, re-
stores N-CoR protein level downregulated by
Siah1/2 overexpression. Similar analysis was
performed for Flag-HDAC3 degradation.
(E) Single cell nuclear microinjection of spe-
cific siRNAs against N-CoR and SMRT abol-
ishes the requirement for TBLR1 for T3R- and
PPAR-mediated transcriptional activation.
TBL1 is required for transcriptional activation
even in absence of N-CoR/SMRT.
(F) N-CoR/SMRT depletion by siRNAs micro-
injection abolishes the need for TBLR1 in
AP1- and RAR-mediated transcriptional acti-
vation events.
(G) Analysis of the occupancy of RAR pro-
moter showed that N-CoR dismissal and
UbcH5 occur by 2 to 5 min after ligand stimu-
lation.
(H) Two-step chromatin immunoprecipitation
was performed showing that UbcH5 is re-
cruited, upon ligand binding to N-CoR bound
RAR promoters with a 45-fold enrichment
of UbcH5 bound chromatin pulled down in
the second step, compared with non-N-CoR
bound promoters.
either the dismissal/degradation of corepressors or the Interestingly, by performing a sequential, two-step chro-
matin immunoprecipitation experiment in 293 cells, firstturnover of the receptor, suggesting that TBL1 plays
additional roles, possibly in the exchange of other core- using-N-CoR IgG and subsequently-UbcH5, we were
able to observe UbcH5 recruitment to N-CoR-occupiedgulators, either corepressors and/or coactivators.
The idea that TBLR1 is required for activation because RAR promoter following 5 min of retinoic acid stimula-
tion (Figure 5H). Because the N-CoR/SMRT corepressorof the necessity of mediating ligand-dependent dis-
missal/degradation of the corepressors raises the inter- complex had been almost completely dismissed (Fig-
ures 5H and 5G), the material pulled down by ChIP duringesting question of whether ligand causes the recruit-
ment of the UbcH5-containing ubiquitination complex the second step with -UbcH5 IgG represented a highly
enriched population of UbcH5/N-CoR-containing pro-to the N-CoR/SMRT bound receptor. First, to confirm the
recruitment of UbcH5-containing ubiquitin machinery moters (45-fold) (Figure 5H). These results suggest
that the UbcH5-containing ubiquitin machinery is re-upon ligand stimulation, we examined the early kinetics
following RA stimulation, finding that UbcH5 is recruited cruited by TBLR1 to the N-CoR bound receptor upon
ligand stimulation, permitting corepressor dismissal andto the RAR promoter upon ligand stimulation and that
most N-CoR dismissal occurs by 2–5 min (Figure 5G). cofactor exchange.
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Adipogenic Differentiation Is Inhibited in TBL1/Y because of its requirement for effective PPAR-induced
gene activation.Embryonic Stem Cells
Thus, as TBL1 is required for transcriptional activation
by many nuclear receptors, independently of the role Discussion
of TBLR1 in N-CoR/SMRT exchange, we investigated
whether the deletion of Tbl1 would be biologically rele- Regulated association of DNA binding transcription fac-
vant for regulated developmental processes. As embry- tors with a series of coactivators and corepressors dic-
onic stem cells can be induced to differentiate in vitro tates the precisely regulated levels of target gene ex-
to form a variety of cell types, essentially recapitulating pression (reviewed in Grandori et al., 2000; Glass and
different stages of murine embryogenesis (reviewed in Rosenfeld, 2000; McKinsey et al., 2001; Levine and Tjian,
Weiss and Orkin, 1996), we took advantage of the ES 2003). In the case of nuclear receptors, the use of a
cell model system to investigate the role of TBL1 in common binding pocket by many coactivators and core-
physiological processes and we tested whether Tbl1 pressors (Hu and Lazar, 1999; Nagy et al., 1999; Perissi
gene deletion would render ES cells unable to undergo et al., 1999; Xu et al., 2002) itself implies a critical regula-
specific differentiation pathways known to be regulated tion of this corepressor/coactivator exchange. Here, we
by nuclear receptors. show that while the F box/WD-40 domain proteins TBL1
First, we analyzed the role of TBL1 for developmental and TBLR1 as intrinsic components of an N-CoR com-
events mediated by the retinoic acid receptor. Retinoic plex can modulate some basal repression events, li-
acid is required for normal development of the mamma- gand-regulated nuclear receptors unexpectedly require
lian brain and promotes neuronal differentiation of mu- TBLR1, and often TBL1, for effective gene activation.
rine ES cells (Bain et al., 1996; Fraichard et al., 1995; The recruitment of TBL1/TBLR1 to both unliganded and
Strubing et al., 1995). Consistent with the data showing liganded nuclear receptors suggests that TBL1/TBLR1
that retinoic acid receptor activation is not dependent may be recruited as an integral component of complexes
on TBL1, we found that embryo bodies derived from playing opposite roles in transcriptional regulation. The
wild-type or Tbl1/Y ES cells were equally able to differ- stability of TBL1/TBLR1 recruitment to liganded recep-
entiate in response to retinoic acid stimulation. Cells tors may also reflect the ability of TBL1/TBLR1 to inter-
with neuronal morphology and expression of specific act with histones, possibly depending on specific cova-
neuronal markers could be identified in the outgrowths lent modifications, in a fashion analogous to the epigenetic
of both wild-type and Tbl1/Y embryo bodies, as shown code used in the ordered recruitment of components of
by immunostaining of 7-day-old embryo bodies with the HO activation machinery (Cosma et al., 1999).
antibodies against -tubulin and TuJ1 (Figure 6A). TBL1 and TBLR1 appear to exert their functions in
Because estrogen and thyroid hormone receptors are transcriptional activation, based on their ability to recruit
not clearly and exclusively associated with specific dif- the ubiquitin/19S proteasome complex to nuclear recep-
ferentiation pathways, we focused on a PPAR-regu- tor-regulated transcription units upon ligand binding, in
lated differentiation process to test whether differentia- concert with the mounting evidence of the important
tion pathways regulated by nuclear receptors that are role of ubiquitylation/proteasomal degradation events
TBL1 dependent, such as ER, T3R, or PPAR, were af- in gene expression (reviewed in Conaway et al., 2002;
fected by Tbl1 gene deletion. Adipogenesis is probably Muratani and Tansey, 2003).
one of the most well described in vitro developmental An intriguing aspect of the role of TBLR1 is that all
processes, during which a well-defined sequence of nuclear receptors analyzed, as well as AP1 and NFB,
events accounts for the differentiation into mature adi- require TBLR1 for transcriptional activation, but that
pocyte (reviewed in Ntambi and Young-Cheul, 2000; Ro- many of these factors, including PPAR, estrogen re-
sen et al., 2000). In order for ES cells to be able to ceptor, thyroid hormone receptor, and NFB, also re-
commit to the adipogenic lineage, embryo bodies re- quire TBL1. We propose that the most critical, specific
quire a short exposure to retinoic acid, after which termi- role of TBLR1 is to mediate the exchange of N-CoR/
nal differentiation is induced by stimulation of PPAR. SMRT corepressor for coactivator complexes, an ex-
Retinoic acid treatment followed by stimulation with adi- change required for transcriptional activation to occur,
pogenic factors leads to differentiation of 60%–80% of based on the fully “revertant” phenotype observed when
the embryo body outgrowth into fat cells, compared to N-CoR and SMRT expression is abolished. Thus, in the
a 2%–5% of differentiated cells that are obtained by absence of N-CoR and SMRT, TBLR1 is no longer re-
spontaneous differentiation in the absence of any stimu- quired for gene activation by thyroid hormone and reti-
lus (reviewed in Rosen et al., 2000; Grimaldi, 2001). noic acid receptors. However, TBL1 is required for tran-
Interestingly, Oil Red O staining of the fat droplets scriptional activation independent of the presence of
showed a marked decrease (to less than 5%–10%) in N-CoR and SMRT, suggesting that TBL1 plays a role in
the number of mature, fully differentiated adipocytes in the exchange of other corepressors and/or in subse-
the outgrowth of Tbl1/Y EBs compared to what was quent steps in transcriptional activation.
observed in their wild-type counterpart (Figure 6B). Fur- Furthermore, the requirement for TBLR1 in activation
thermore, the expression of a downstream PPAR target of AP1-dependent targets, and of both TBLR1 and TBL1
gene, such as the fat cell marker adipsin, was clearly for activation of NFB targets, indicates that, as in
reduced in the absence of TBL1 (Figure 6C). Together, the case of nuclear receptors, the TBLR1-mediated ex-
these data suggest that TBL1 is required for effective change of corepressors is also a central aspect in
growth and inflammatory signaling events.commitment of ES cells to the adipogenic fate, probably
Cell
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Figure 6. TBL1 Is Required for ES Cells Differentiation into the Adipogenic Lineage and Not for Differentiation into the Neuronal Lineage
(A) Immunofluorescence staining of 7-day-old embryo bodies (EBs) treated with RA to induce neuronal differentiation, as shown in the
schematic. -TBL1 immunostaining in the top panel confirms that TBL1 expression is absent in Tbli/Y ES cells. Immununofluorescence with
-tubulin and Tuj1 in the lower panels shows the presence of neuronal-like cells in the outgrowths of differentiated wild-type and Tbli/Y
EBs. In the upper four panels, nuclear 4,6-diamidino-2-phenylindole (DAPI) staining is indicated in blue.
(B) Red Oil O staining of EBs 5 days after the adipogenic differentiation is induced with Dex/MIX/insulin as indicated in the schematic (10
or 32 magnification).
(C) RT-PCR analysis of adipogenic markers PPAR and adipsin in wild-type, and Tbli/Y EBs were examined in embryo bodies induced to
differentiate with Insulin/Dex/MIX or left untreated.
Zhang and colleagues (1998) have reported that Interestingly, modulation of degradation events is of-
ten achieved by phosphorylation of the substrate. ForN-CoR degradation by the 26S proteasome is based on
the recruitment of the E3 ubiquitin ligase Siah1/2. We example, the F box/WD-40 protein -TrCP recognizes
-catenin phosphorylated by GSK3 (at Ser32 and Ser36),have shown here that TBL1/TBLR1 mediates N-CoR
proteasomal degradation in vitro, and thus suspect that targeting it for ubiquitylation and destruction (Wu et al.,
2003). Interestingly, during UV stress, the binding ofin vivo Siah1/2 may require TBLR1 for specific recogni-
tion of N-CoR as a substrate, analogous to the case of -catenin to Ebi, the Drosophila homolog of TBL1/
TBLR1, is independent of the phosphorylation sites rec--catenin and Tramtrack88 (Dong et al., 1999; Matsu-
zawa and Reed, 2001). This is consistent with the genetic ognized by -TrCP. However, the TBLR1 putative target,
N-CoR, has multiple regulatory phosphorylation sites,data presented by Tsuda et al. (2002), which suggested
that in Drosophila eye development, Ebi/TBL1 is re- some of which have been linked to nuclear-cytoplasmic
translocation and possibly to degradation (Hong andquired for EGFR-induced expression of the Notch li-
gand, Delta, because of the necessity to antagonize the Privalsky, 2000; Hermanson et al., 2002), suggesting that
N-CoR phosphorylation may represent a mark for pro-repressor function of Suppressor of Hairless [Su(H)] by
nuclear export and perhaps proteasomal degradation tein ubiquitylation and degradation.
We are tempted to speculate that TBL1-selective re-of the Drosophila N-CoR homolog, SMRTER. Thus, the
presence of TBL1/TBLR1/Ebi in repressor complexes, quirement by some of the DNA binding transcription
factors examined may reflect the exchange of corepres-such as the Sno/Ebi/SMRTER/Su(H) (Tsuda et al., 2002)
or the TBL1/N-CoR/HDAC3/Six6 that we have pre- sors other than N-CoR/SMRT, or perhaps one or more
of the coactivators, or ligand-dependent corepressorsviously described in the case of Six6-mediated repres-
sion of the p27Kip1 gene (Li et al., 2002), may reflect such as L-CoR or REA (Fernandes et al., 2003; Delage-
Mourroux et al., 2000). The TBLR1- and TBL1-recruitedthe fact that TBL1/TBLR1 play a role for the effective
dismissal of the corepressors for these DNA binding ubiquitin/19S proteasome complexes may also have
nonproteolytic functions, including possibly the modula-transcription factors.
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Figure 7. Model of TBL1/TBLR1 Functions in
Transcriptional Regulation
TBLR1 is required for transcriptional activa-
tion mediated by all nuclear receptors exam-
ined, as well as in regulation of AP1 and NFB,
while TBL1 is required by a subset of nuclear
receptors. Regulation of transcriptional acti-
vation by retinoic acid receptor upon ligand
binding, where TBLR1 specifically serves as
a nuclear receptor corepressor/coactivator
exchange factor (N-CoEx), required for the
dismissal and subsequent degradation of the
corepressors N-CoR/SMRT and for the sub-
sequent recruitment of the coactivator com-
plexes, which will lead to target genes activa-
tion and differentiation programs. Analogous
exchange functions are suggested for TBL1.
tion and recruitment of other enzymatic activities, as portant developmental programs. The biological conse-
quences of the loss of Tbl1 include a 90%–95% loss inwell as the reconfiguration of chromatin. Indeed, it is
becoming increasingly clear that multiple coactivator adipocyte differentiation triggered by PPAR induction
in Tbl1/Y ES cells and a significant loss in thyroid hor-and corepressor complexes are required for transcrip-
tional events because of the necessity for multiple, dis- mone receptor-dependent activation of target genes, as
assessed by RNA profiling. In contrast, retinoic acidtinct catalytic activities. Correspondingly, actions of dis-
tinct ubiquitin/proteasome complexes are also likely to receptor, which is TBL1 independent, was able to acti-
vate a normal program of neuronal differentiation inbe central to different points of control of transcriptional
activation, suggesting that recruitment of the 19S pro- Tbl1/Y ES cells, including a correct regulation of virtu-
ally all retinoic acid-dependent gene targets, as revealedteasome is needed for multiple functions and probably
achieved through more than a single specific mecha- by RNA profiling. Depletion of either TBL1 or TBLR1
by specific siRNAs in TNF-stimulated endothelial cellsnism and leaving open the possibility that the exchange
appeared to result in significant inhibition of the NFB-and dismissal of N-CoR/SMRT is not inevitably linked
dependent gene activation program.to their degradation. Analysis of the requirement for
In conclusion, we suggest that TBL1 and TBLR1 con-different ubiquitin-conjugating enzymes and ubiquitin
stitute a specific class of coregulators, distinct fromligases showed that, while UbcH5, as well as TBL1/
other classes of coactivators and corepressors, whichTBLR1, was required for transcriptional activation by all
play important roles in both activation and repression,the nuclear receptors examined, additional components
acting as nuclear receptor corepressor/coactivator ex-of the ubiquitin/19S proteasome machinery could be
change factors (N-CoEx), required for modulating regu-required by specific receptors. This is consistent with
lated gene transcription by nuclear receptors and otherthe idea that receptors, coactivators, and other compo-
classes of DNA binding transcription factors (Figure 7).nents of the transcriptional machinery are undergoing
continuous turnover.
Experimental ProceduresAs an independent confirmation of this overlapping,
but distinct specificity between TBL1 and TBLR1, we Reagents and Antibodies
have shown a TBL1-selective requirement for effective Anti-TBL1 antibody was generated in guinea pigs against
bacterially expressed N-terminal region of murine TBL1. Anti-gene activation by specific nuclear receptors during im-
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